Literature DB >> 21142691

Antibiotics for both moderate and severe cholera.

Eric J Nelson1, Danielle S Nelson, Mohammed A Salam, David A Sack.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 21142691     DOI： 10.1056/NEJMp1013771

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  37 in total

1.  The time of cholera.

Authors:  David N Fisman; Kevin Laupland
Journal:  Can J Infect Dis Med Microbiol       Date:  2011       Impact factor: 2.471

2.  Vibrio cholerae antimicrobial drug resistance, Papua New Guinea, 2009-2011.

Authors:  Manoj Murhekar; Samir Dutta; Berry Ropa; Rosheila Dagina; Enoch Posanai; Alexander Rosewell
Journal:  Western Pac Surveill Response J       Date:  2013-09-02

Review 3.  Cholera.

Authors:  Jason B Harris; Regina C LaRocque; Firdausi Qadri; Edward T Ryan; Stephen B Calderwood
Journal:  Lancet       Date:  2012-06-30       Impact factor: 79.321

4.  Reassessment of the 2010-2011 Haiti cholera outbreak and rainfall-driven multiseason projections.

Authors:  Andrea Rinaldo; Enrico Bertuzzo; Lorenzo Mari; Lorenzo Righetto; Melanie Blokesch; Marino Gatto; Renato Casagrandi; Megan Murray; Silvan M Vesenbeckh; Ignacio Rodriguez-Iturbe
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-13       Impact factor: 11.205

5.  Transmission dynamics and control of cholera in Haiti: an epidemic model.

Authors:  Jason R Andrews; Sanjay Basu
Journal:  Lancet       Date:  2011-03-15       Impact factor: 79.321

6.  3-Amino 1,8-naphthalimide, a structural analog of the anti-cholera drug virstatin inhibits chemically-biased swimming and swarming motility in vibrios.

Authors:  Hongxia Wang; Anisia J Silva; Jorge A Benitez
Journal:  Microbes Infect       Date:  2017-04-06       Impact factor: 2.700

7.  A quinazoline-2,4-diamino analog suppresses Vibrio cholerae flagellar motility by interacting with motor protein PomB and induces envelope stress.

Authors:  Hongxia Wang; Li Zhang; Anisia J Silva; Jorge A Benitez
Journal:  Antimicrob Agents Chemother       Date:  2013-06-03       Impact factor: 5.191

8.  Zinc oxide nanoparticles provide anti-cholera activity by disrupting the interaction of cholera toxin with the human GM1 receptor.

Authors:  Shamila Sarwar; Asif Ali; Mahadeb Pal; Pinak Chakrabarti
Journal:  J Biol Chem       Date:  2017-09-07       Impact factor: 5.157

9.  Cholera outbreak in districts around Lake Chilwa, Malawi: lessons learned.

Authors:  Amin Khonje; Carol Ann Metcalf; Emma Diggle; Dudley Mlozowa; Chandiwira Jere; Ann Akesson; Tom Corbet; Zachariah Chimanga
Journal:  Malawi Med J       Date:  2012-06       Impact factor: 0.875

Review 10.  Achievements and challenges for the use of killed oral cholera vaccines in the global stockpile era.

Authors:  Sachin N Desai; Lorenzo Pezzoli; Kathryn P Alberti; Stephen Martin; Alejandro Costa; William Perea; Dominique Legros
Journal:  Hum Vaccin Immunother       Date:  2017-03-04       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.